BC
ERAS icon

Boxer Capital’s Erasca ERAS Stock Holding History

Boxer Capital’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-450,000
Closed -$9.55M – 76
2021
Q3 		$9.55M Buy
+450,000
New +$9.28M 0.33% 63

Other funds holding ERAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AEPBI
AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Boxer Capital's ERAS Position: Q4 2021 in Review

Boxer Capital sold out of Erasca (ERAS) in Q4 2021, closing a stake of 450,000 shares — an estimated $9.55M sold.

Boxer Capital first reported a position in ERAS in Q3 2021 and held it in 1 quarter. The position peaked at $9.55M in Q3 2021. 63 funds tracked by Wall St. Rank hold ERAS as of Q4 2021.

  • Boxer Capital reported no remaining Erasca position as of Q4 2021 after selling out during the quarter.
  • Boxer Capital sold 450,000 Erasca shares in Q4 2021, an estimated $9.55M.
  • Boxer Capital first reported a position in Erasca in Q3 2021 and held it in 1 quarter.
  • Boxer Capital's Erasca position peaked at $9.55M in Q3 2021.
  • 63 funds tracked by Wall St. Rank held Erasca as of Q4 2021.

Based on Boxer Capital's 13F filing for Q4 2021, filed 14 Feb 2022.